Image

The Role of the Brain in Mental and Physical Fatigue

Recruiting
18 - 35 years of age
Both
Phase 3

Powered by AI

Overview

The goal of this clinical trial is to determine the role of brain neurotransmission in the onset of fatigue, identify the brain areas involved, and determine how brain activity and neuromuscular efficiency changes during onset of fatigue. Three different experimental studies (physical fatigue, mental fatigue and combined) will be performed with a randomized, single-blinded, placebo controlled, counter-balanced, cross-over design.

The objectives of the projects are as follows:

  • To experimentally assess the role of a dopamine, and a noradrenalin reuptake inhibitor in the onset of exercise-induced fatigue
  • To identify changes in brain activation associated with altered PF and fatigue perception
  • To experimentally assess the effect of a NA or DA reuptake inhibitor on MF, brain activation and the sources of changes in brain activation
  • To experimentally assess the role of brain neurotransmitters (DA, NA) in the interaction between mental and PF from a neurophysiological perspective.

Participants will be healthy young adults. In each study, they will start with a familiarization trial followed by two experimental trials and one control trial with a randomized treatment order. At each visit, different drugs will be administered to elicit different neurotransmitter response. The trials will be performed at the MFYS exercise lab (BLITS, VUB campus Etterbeek, Boulevard General Jaques 271, 1050 Elsene (Brussels)).

Depending on the type of study they are participating in, participants will perform three distinct tasks:

  • In the first experimental study participants will perform a 60-min Stroop Task to elicit mental fatigue.
  • In the second experimental study participants will perform a knee-extension exercise until exhaustion to elicit physical fatigue.
  • In third experimental study participants will first preform a mental fatiguing task (Stroop taks) followed by physical fatigue task (knee extension).

While participants will perform above mentioned task their EEG signal and heart rate will be measured. At the same time, participants will report on their subjective feeling of fatigue during these tasks. In addition, all participants will be administered cognitive tasks before and after the study, along with questionnaires. In the second and third experiments, tensiomyography and electromyography will also be recorded from the quadriceps muscle of the leg used for knee extension.

Researchers will compare physiological and behavioural changes in response to specific neurotransmitter drug to answer the main question: what the role of a DA and a NA reuptake inhibitor on the onset of mental and physical fatigue is.

Eligibility

Inclusion Criteria:

  • Healthy trained individuals (exercises at least 1x per week, no neurological, cardiovascular internal or musculoskeletal disorders of any kind)
  • No use of chronic or occasional prescribed medication (except for contraceptives)
  • Non-smoker

Exclusion Criteria:

  • Injuries of any kind in the past 6 months
  • Pregnancy
  • Specific food or drink allergies (e.g. lactose and/or gluten intolerance)
  • Suffering from a chronic health condition (could be neurological, cardiovascular, internal and musculoskeletal)
  • Participating in any concomitant care or research trials
  • History of suffering from any mental/psychiatric disorders:
        Suffering from a higher risk of burn out, indicated by a total score of more than 2.59 on
        the Burn out assessment tool (BAT) Suffering from high general fatigue, indicated by a
        score of more than 57 on the Multidimensional fatigue inventory (MFI) Suffering from
        depression, indicated by a score of more than16 on the Beck depression inventory-II
        (BDI-II)
          -  Use of medication Chronic use with an exception for contraceptives Prescribed
             medication in between or before trials Use of non-prescribed occasional medication 24
             hours prior each trial
          -  Use of caffeine and heavy efforts 24 hours prior each trial
          -  Suffering from colour vision deficiencies
          -  Not eating a standardized meal, the morning of each trial

Study details

Fatigue

NCT05880342

Vrije Universiteit Brussel

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.